US Congress HR6050

A bill to amend the Federal Food, Drug, and Cosmetic Act, the Federal Trade Commission Act, and title 18 of the United States Code to increase the criminal penalties for those who willfully sell or offer for sale drugs, devices, or medical treatment knowing that it is unsafe or ineffective or unproven for safety or efficacy.